¿Podría el Ativan ser peligroso para las personas con un cáncer de páncreas?
JUEVES, 17 de agosto de 2023 (HealthDay News) — A veces, a las personas con un cáncer de páncreas les recetan lorazepam (Ativan), una benzodiacepina, para la ansiedad, pero podría estar dañando su salud. Un nuevo estudio encontró que este tratamiento…
Learn MoreCould Ativan Pose Harm to People Battling Pancreatic Cancer?
THURSDAY, Aug. 17, 2023 (HealthDay News) — Sometimes patients with pancreatic cancer are prescribed the benzodiazepine lorazepam (Ativan) for anxiety, but that may be harming their health. A new study found this treatment was linked to worse outcomes…
Learn MoreModerna COVID-19 Vaccine Tied to Lower Adverse Event Risk in Older Adults
FRIDAY, Aug. 11, 2023 (HealthDay News) — The mRNA-1273 (Moderna) vaccine against COVID-19 is associated with a slightly lower risk for several adverse events in older adults compared with BNT162b2 (Pfizer), according to a study published online Aug. …
Learn MoreSymptoms, Negative Life Impact Seen During, After Benzodiazepine Use
TUESDAY, Aug. 8, 2023 (HealthDay News) — Benzodiazepine-induced neurological dysfunction is commonly reported by current and former benzodiazepine users, according to a study published online June 29 in PLOS ONE.Alexis D. Ritvo, M.D., M.P.H., from th…
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach problems.The lawsuit seeks “very signific…
Learn MoreOne-Hour Training Improves Documentation to Diagnose, Treat Tardive Dyskinesia
TUESDAY, July 18, 2023 (HealthDay News) — An annual one-hour Abnormal Involuntary Movement Score (AIMS) training session improves documentation to recognize and treat tardive dyskinesia in the psychiatry outpatient clinic, according to a study recent…
Learn MoreChemotherapy-Induced Pseudocellulitis Described in Case Reports
WEDNESDAY, July 5, 2023 (HealthDay News) — Chemotherapy-induced adverse cutaneous drug reactions that mimic cellulitis, including those termed pseudocellulitis, do not meet criteria for other diagnoses, according to a review published online June 28 …
Learn MoreSex Differences Seen in Cognitive Impairment for Tardive Dyskinesia in Schizophrenia
FRIDAY, May 19, 2023 (HealthDay News) — For schizophrenia patients with tardive dyskinesia (TD), there may be sex differences in cognitive impairment, with a protective effect suggested by female gender, according to a study published in the May issu…
Learn MoreNew Treatment Could Be Safer Way to Fight Brain Tumors in Kids
TUESDAY, April 25, 2023 (HealthDay News) — Each year, about 140 kids in the United States are diagnosed with a craniopharyngioma, a typically non-cancerous brain tumor that develops near the pituitary gland at the base of the brain.Doctors treat cran…
Learn MoreAdverse Events Detailed for Teen COVID-19 Vaccination Program
FRIDAY, April 21, 2023 (HealthDay News) — For adolescents aged 12 to 17 years, most reported adverse events following BNT162b2 vaccination are mild and self-limited, according to a study published online April 21 in Pediatrics.Elizabeth M. Hesse, M.D…
Learn More